US Government Stake Speculation IonQ Micron and Anduril Emerge as Potential Targets After Quantum Investments Steel Stocks Surge as Government Extends Minimum Import Price on 66 Steel Products LIC HDFC Bank Lead Seven Top Movers in Wednesday Trading Mercury Secures 200M Funding at 52 Billion Valuation Signaling Resilience in Fintech Sector Kevin Warsh Set to Assume Federal Reserve Chairmanship on Friday Barclays Initiates Coverage of FreeportMcMoRan with Overweight Rating on Copper Demand Outlook CSIQ Q1 2026 Earnings NarrowerThanExpected Loss Shows Cost Discipline Amid Solar Market Challenges FTFT Q2 2024 Earnings Loss Per Share of 009 as Stock Rises AIT Q1 2026 Earnings Narrow Profit Miss Amidst Steady Operational Performance Grupo Aeroportuario del Sureste SA de CV ASR Q1 2026 Earnings EPS Miss Weighs on Shares Despite Steady Traffic Trends SYF Q1 2026 Earnings Earnings Beat Estimates Amid Stable Credit Trends CTNT Q1 2026 Earnings NarrowerThanExpected Loss Signals Cost Management Amidst Revenue Uncertainty Foxx Development Holdings FOXX Plunges Nearly 16 as Selling Pressure Intensifies Xtant Medical Holdings Holds Near Key Resistance Level After Modest Gain BlackRock Credit Allocation Income Trust BTZ Edges Higher as Income Investors Test Resistance HealthEquity HQY Shows Modest Gains After Support Test Concorde International Group Ltd CIGL Holds Steady at 199 Consolidation Signals Caution Navigating Finances After Marriage Combined vs Separate Accounts GPUS Q3 2025 Earnings Losses Persist as Hyperscale Data Ramps Up Investment Vox Royalty Corp VOXR Surges Over 5 Key Support and Resistance Levels in Focus YUMC Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower VKTX Q1 2026 Earnings WiderthanExpected Loss in a PreRevenue Stage Universal Display Corporation Q1 2026 Earnings EPS Misses Estimates by a Wide Margin FUNC Q1 2026 Earnings Strong EPS Beat Despite Negative Market Reaction Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses CLGN Q4 2025 Earnings EPS Misses Estimates as Biotech Continues PreRevenue Phase BLSH Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction